{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:12:23Z","timestamp":1792131143724,"version":"4.4.0"},"reference-count":35,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["Core Grant 1006680\/B\/14\/Z"],"award-info":[{"award-number":["Core Grant 1006680\/B\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The pathognomonic feature of dengue shock syndrome (DSS) is a transient capillary leak syndrome resulting in profound intravascular volume depletion. WHO management guidelines recommend particular parenteral fluid regimens during the critical leakage phase, including synthetic colloid solutions in certain circumstances. We set out to describe the actual fluid management strategies employed in different settings and to investigate relationships with clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective review of paediatric DSS cases managed at seven hospitals across Malaysia, Myanmar and Vietnam. We explored the effects of both initial resuscitation (crystalloid alone or mixed crystalloid\/colloid in the first 2\u2009hours) and general management: group 1 (conservative-colloid, crystalloid only), group 2 (intermediate-colloid, colloid for 1\u20134\u2009hours) or group 3 (liberal-colloid, continuous colloid for more than 4\u2009hours) categorised according to the fluid given over the first 6\u2009hours in clinically stable patients. We incorporated an inverse probability weighting score to adjust for potential differences in baseline severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among all 691 patients, respiratory compromise (HR 2.08, p=0.022), requirement for nasal continuous positive airway pressure (NCPAP)\/ventilation (OR 2.34, p&lt;0.045) and days in hospital after DSS onset (risk ratio, RR 1.33, p=0.032) were significantly worse for mixed crystalloid\/colloid versus crystalloid-only initial resuscitation regimens, after adjusting for baseline severity. Among the 547\/691 children who stabilised within 2\u2009hours, although a liberal-colloid general management strategy (group 3) was associated with a reduction in recurrent shock episodes (RR 0.13, p=0.043) when compared with a conservative-colloid strategy (group 1), the risks for respiratory compromise (OR 8.84, p&lt;0.001) and requirement for NCPAP\/ventilation (OR 8.16, p&lt;0.001) were markedly increased. Additionally, the respective costs for group 3 vs group 1 were significantly higher.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The study highlights the potential benefits and risks of using colloid solutions in children with DSS. Formal randomised trials could help determine the most effective and safe parenteral fluid regimens for paediatric DSS. In the meantime, prolonged use of colloid solutions may be inappropriate, especially in settings without access to respiratory support.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-017538","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T21:45:16Z","timestamp":1741729516000},"page":"e017538","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["The influence of fluid resuscitation strategy on outcomes from dengue shock syndrome: a review of the management of 691 children in 7 Southeast Asian hospitals"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-6548","authenticated-orcid":false,"given":"Huynh Trung","family":"Trieu","sequence":"first","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam"},{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Lam","family":"Vuong","sequence":"additional","affiliation":[{"name":"Dengue, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"},{"name":"University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thanh","family":"Hung","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital 1, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Nguyen Minh","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Chau","family":"Nguyen Van","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu Qui","family":"Phan","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong An","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, Ho Chi Minh, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Nguyen Thi Minh","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Nguyen Thi Truong","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em Jun","family":"Min","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng Kai","family":"Voon","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Chan Huey","family":"Ling","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hue Yuen","family":"Ling","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lim Eng","family":"Seng","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Lum Chai","family":"See","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifah","family":"Faridah Syed Omar","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnasewary","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Hospital Ampang, Ampang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiu Jer","family":"Ling","sequence":"additional","affiliation":[{"name":"Hospital Kajang, Kajang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia Zubaidah","family":"Bahtar","sequence":"additional","affiliation":[{"name":"Hospital Kajang, Kajang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachal","family":"Nachiappan","sequence":"additional","affiliation":[{"name":"Hospital Tengku Ampuan Rahima, Klang, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw Zin","family":"Wai","sequence":"additional","affiliation":[{"name":"Yankin Children\u2019s Hospital, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyi San","family":"Thi","sequence":"additional","affiliation":[{"name":"Yankin Children\u2019s Hospital, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Mon","family":"Lwin","sequence":"additional","affiliation":[{"name":"Yankin Children\u2019s Hospital, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Ward","sequence":"additional","affiliation":[{"name":"Royal College of Paediatrics and Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Ward","sequence":"additional","affiliation":[{"name":"Royal College of Paediatrics and Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-5962","authenticated-orcid":false,"given":"Hung","family":"Trinh","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung Khanh","family":"Lam","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Wills","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2025073013111018000_10.3.e017538.1","unstructured":"WHO . Dengue and severe dengue. 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue [Accessed 18 Jan 2024]."},{"key":"2025073013111018000_10.3.e017538.2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature New Biol"},{"key":"2025073013111018000_10.3.e017538.3","unstructured":"WHO . Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva New Edition; 2009."},{"key":"2025073013111018000_10.3.e017538.4","doi-asserted-by":"publisher","DOI":"10.1086\/341410"},{"key":"2025073013111018000_10.3.e017538.5","unstructured":"World Health Organization . Handbook for Clinical Management of Dengue. 2012."},{"key":"2025073013111018000_10.3.e017538.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit594"},{"key":"2025073013111018000_10.3.e017538.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005740","article-title":"Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress","volume":"11","author":"Yacoub","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073013111018000_10.3.e017538.8","doi-asserted-by":"publisher","DOI":"10.1086\/318479"},{"key":"2025073013111018000_10.3.e017538.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2018.07.007"},{"key":"2025073013111018000_10.3.e017538.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044057"},{"key":"2025073013111018000_10.3.e017538.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209759"},{"key":"2025073013111018000_10.3.e017538.12","unstructured":"European MA . Hydroxyethyl starch solutions for infusion, 2014. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/hydroxyethyl-starch-solutions-infusion [Accessed 02 Mar 2022]."},{"key":"2025073013111018000_10.3.e017538.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0702-y","article-title":"Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials","volume":"18","author":"Xu","year":"2014","journal-title":"Crit Care"},{"key":"2025073013111018000_10.3.e017538.14","unstructured":"IndianAcademyofPediatrics . Standard treatment guidelines: dengue in children. 2022. Available: https:\/\/iapindia.org\/pdf\/Ch-138-Dengue-in-Children.pdf [Accessed 15 Oct 2023]."},{"key":"2025073013111018000_10.3.e017538.15","unstructured":"Ministry of Health Malaysia . Clinical practice guidelines on management of dengue in children. 2020. Available: https:\/\/www.moh.gov.my\/moh\/resources\/Penerbitan\/CPG\/Infectious%20Disease\/CPG_Management_of_Dengue_in_Children_06072021.pdf [Accessed 15 Oct 2023]."},{"key":"2025073013111018000_10.3.e017538.16","unstructured":"Philippine Pediatric Society . Clinical Practice Guidelines on Dengue in Children, 2017. Available: http:\/\/www.pidsphil.org\/home\/wp-content\/uploads\/2017\/06\/2017_Dengue_CPG_Final.pdf [Accessed 15 Oct 2023]."},{"key":"2025073013111018000_10.3.e017538.17","unstructured":"Sear W . Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. 2011. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/204894 [Accessed 22 Feb 2022]."},{"key":"2025073013111018000_10.3.e017538.18","unstructured":"Vietnam MoH . Guideline of dengue diagnosis and management, 2019. Available: https:\/\/luatvietnam.vn\/y-te\/quyet-dinh-3705-qd-byt-2019-huong-dan-chan-doan-dieu-tri-sot-xuat-huyet-dengue-176501-d1.html [Accessed 02 Mar 2022]."},{"key":"2025073013111018000_10.3.e017538.19","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v043.i10"},{"key":"2025073013111018000_10.3.e017538.20","unstructured":"Siripen K . Standardized clinical management: evidence of reduction of dengue haemorrhagic fever case-fatality rate in thailand. 1999. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/148661 [Accessed 20 Jun 2022]."},{"key":"2025073013111018000_10.3.e017538.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-3111-9"},{"key":"2025073013111018000_10.3.e017538.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f839","article-title":"Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis","volume":"346","author":"Haase","year":"2013","journal-title":"BMJ"},{"key":"2025073013111018000_10.3.e017538.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-2840-0"},{"key":"2025073013111018000_10.3.e017538.24","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-12-24","article-title":"Comparing the effect of hydroxyethyl starch 130\/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis\/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial","volume":"12","author":"Perner","year":"2011","journal-title":"Trials"},{"key":"2025073013111018000_10.3.e017538.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242"},{"key":"2025073013111018000_10.3.e017538.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001282","article-title":"Dextran fractional clearance studies in acute dengue infection","volume":"5","author":"Nguyen-Pouplin","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073013111018000_10.3.e017538.27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.278.1.H285"},{"key":"2025073013111018000_10.3.e017538.28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/520435","article-title":"Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens","volume":"29","author":"Dung","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2025073013111018000_10.3.e017538.29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/tmi.12666","article-title":"Vascular leakage in dengue--clinical spectrum and influence of parenteral fluid therapy","volume":"21","author":"Rosenberger","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2025073013111018000_10.3.e017538.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101549"},{"key":"2025073013111018000_10.3.e017538.31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.601520","article-title":"Microvascular Fluid Exchange: Implications of the Revised Starling Model for Resuscitation of Dengue Shock Syndrome","volume":"7","author":"Trung","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2025073013111018000_10.3.e017538.32","unstructured":"Agency EM . Hydroxyethyl-starch solutions for infusion recommended for suspension from the market, 2022. Available: https:\/\/www.ema.europa.eu\/en\/news\/hydroxyethyl-starch-solutions-infusion-recommended-suspension-market [Accessed 26 Mar 2024]."},{"key":"2025073013111018000_10.3.e017538.33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/cc13027","article-title":"Should hydroxyethyl starch solutions be totally banned?","volume":"17","author":"Vincent","year":"2013","journal-title":"Crit Care"},{"key":"2025073013111018000_10.3.e017538.34","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2018.00336","article-title":"Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union","volume":"5","author":"Adamik","year":"2018","journal-title":"Front Vet Sci"},{"key":"2025073013111018000_10.3.e017538.35","doi-asserted-by":"crossref","unstructured":"Chappell D , Jacob M . Should hydroxyethyl starch be banned? Lancet 2018;392. doi:10.1016\/S0140-6736(18)31174-7","DOI":"10.1016\/S0140-6736(18)31174-7"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-017538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:11:19Z","timestamp":1753906279000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-017538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,11]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjgh-2024-017538"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-017538","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}